Aboagye EO - Search Results

1

Feasibility of [¹⁸F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study.

Islam S, Inglese M, Grech-Sollars M, Aravind P, Dubash S, Barwick TD, O'Neill K, Wang J, Saleem A, O'Callaghan J, Anchini G, Williams M, Waldman A, Aboagye EO. Islam S, et al. Among authors: aboagye eo. Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3982-3995. doi: 10.1007/s00259-023-06330-0. Epub 2023 Jul 25. Eur J Nucl Med Mol Imaging. 2023. PMID: 37490079 Free PMC article.

2

In vivo monitoring of drugs using radiotracer techniques.

Saleem A, Aboagye EO, Price PM. Saleem A, et al. Among authors: aboagye eo. Adv Drug Deliv Rev. 2000 Mar 15;41(1):21-39. doi: 10.1016/s0169-409x(99)00054-x. Adv Drug Deliv Rev. 2000. PMID: 10699303 Review.

3

Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action.

Saleem A, Yap J, Osman S, Brady F, Suttle B, Lucas SV, Jones T, Price PM, Aboagye EO. Saleem A, et al. Among authors: aboagye eo. Lancet. 2000 Jun 17;355(9221):2125-31. doi: 10.1016/s0140-6736(00)02380-1. Lancet. 2000. PMID: 10902627 Clinical Trial.

4

Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer.

Aboagye EO, Saleem A, Cunningham VJ, Osman S, Price PM. Aboagye EO, et al. Cancer Res. 2001 Jul 1;61(13):4937-41. Cancer Res. 2001. PMID: 11431319

5

Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET.

Brady F, Luthra SK, Brown GD, Osman S, Aboagye E, Saleem A, Price PM. Brady F, et al. Curr Pharm Des. 2001 Dec;7(18):1863-92. doi: 10.2174/1381612013396907. Curr Pharm Des. 2001. PMID: 11772355 Review.

6

The uptake of 3'-deoxy-3'-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels.

Barthel H, Perumal M, Latigo J, He Q, Brady F, Luthra SK, Price PM, Aboagye EO. Barthel H, et al. Among authors: aboagye eo. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):257-63. doi: 10.1007/s00259-004-1611-0. Epub 2004 Sep 4. Eur J Nucl Med Mol Imaging. 2005. PMID: 15791434

7

Elevation of radiolabelled thymidine uptake in RIF-1 fibrosarcoma and HT29 colon adenocarcinoma cells after treatment with thymidylate synthase inhibitors.

Yau K, Price P, Pillai RG, Aboagye E. Yau K, et al. Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):981-7. doi: 10.1007/s00259-005-0060-8. Epub 2006 Mar 28. Eur J Nucl Med Mol Imaging. 2006. PMID: 16568206

8

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

Kenny L, Coombes RC, Vigushin DM, Al-Nahhas A, Shousha S, Aboagye EO. Kenny L, et al. Among authors: aboagye eo. Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1339-47. doi: 10.1007/s00259-007-0379-4. Epub 2007 Mar 2. Eur J Nucl Med Mol Imaging. 2007. PMID: 17333178

9

An in vivo multimodal imaging study using MRI and PET of stem cell transplantation after myocardial infarction in rats.

Chapon C, Jackson JS, Aboagye EO, Herlihy AH, Jones WA, Bhakoo KK. Chapon C, et al. Among authors: aboagye eo. Mol Imaging Biol. 2009 Jan-Feb;11(1):31-8. doi: 10.1007/s11307-008-0174-z. Epub 2008 Sep 5. Mol Imaging Biol. 2009. PMID: 18773246

10

A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patients.

Rosso L, Brock CS, Gallo JM, Saleem A, Price PM, Turkheimer FE, Aboagye EO. Rosso L, et al. Among authors: aboagye eo. Cancer Res. 2009 Jan 1;69(1):120-7. doi: 10.1158/0008-5472.CAN-08-2356. Cancer Res. 2009. PMID: 19117994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters